How to Read Peptide Evidence
A BS detector for health claims

Most peptide information online skips the part where it tells you whether a claim comes from a landmark FDA approval or a single study in eight mice. This guide teaches you what to look for.

01 — The basics

Why evidence quality matters

Most peptide information online doesn't tell you whether a claim is backed by an FDA approval or a single mouse study. A compound that "reduces inflammation" could mean it earned regulatory approval after years of clinical trials — or it means someone injected a rat's knee and measured the swelling go down 14%.

Those are not the same thing. BadgerSkope uses a 6-tier evidence system so you always know what you're looking at. No inflated language. No hidden context. Just the actual level of proof behind every claim.

02 — The system

The six evidence tiers

Every compound and every claim in BadgerSkope is tagged with one of these tiers. Here's what each one actually means.

FDA Approved

The gold standard

This compound has gone through the full regulatory process. A pharmaceutical company submitted safety and efficacy data, and a government agency reviewed and approved it. Real prescribing information exists. Doctors can legally prescribe it for specific conditions.

What to expect: large-scale data, known side-effect profiles, established dosing, post-market surveillance.

Examples: Semaglutide for diabetes, Tesamorelin for HIV lipodystrophy, Bremelanotide (PT-141) for HSDD

Strong Human Trials

Serious data, not yet approved

Major clinical trials — Phase 2 or Phase 3 — with hundreds or thousands of human participants. The drug may not be approved yet, but the data is serious. These are the studies that get published in top journals and drive approval applications.

What to expect: controlled study designs, statistical significance, safety monitoring, peer-reviewed publications.

Examples: Tirzepatide weight loss trials (SURMOUNT), Retatrutide phase 2 data, Survodutide

Early Human Studies

Promising signals, not proof

Phase 1 or small human studies. These mainly test safety and basic pharmacological effects in healthy volunteers or small patient groups. You might see interesting signals, but the sample sizes are too small and the designs too preliminary to call anything conclusive.

What to expect: safety/tolerability data, pharmacokinetic profiles, preliminary efficacy hints, small sample sizes.

Examples: Ipamorelin pharmacology studies, Kisspeptin fertility infusions, Semax/Selank regional clinical use

Animal Studies Only

Worked in mice. That's it.

The evidence comes from mice, rats, or cell cultures. This is where most "breakthrough" peptide claims originate. It's real science, and it matters — but there's a critical caveat: most things that work in mice don't work in humans. The failure rate from animal models to human efficacy is roughly 90%.

What to expect: preclinical data only, no human safety profile, speculative dosing, unknown side effects in people.

Examples: BPC-157 tendon healing, FOXO4-DRI senescent cell clearance, SLU-PP-332 exercise mimetic, MOTS-c metabolism

Clinic Practice

Experience, not experiments

Used in wellness clinics or compounding pharmacies based on clinical experience rather than controlled trials. The evidence is anecdotal or based on small uncontrolled observations. Practitioners may swear by it, but "I've seen it work" is not the same as "we tested it rigorously."

What to expect: anecdotal reports, practitioner protocols, no control groups, potential placebo effects, selection bias.

Examples: LIPO-C fat-burning shots, GH secretagogue "stacks," some bioregulator courses

Unknown

Can't confirm what's in the tin

The active ingredient or evidence basis couldn't be confirmed. This might be a proprietary blend, a novel vendor formulation, or something where the claimed mechanism doesn't match any published research. Treat with maximum skepticism.

What to expect: no verifiable data, unclear composition, possible marketing-only claims.

Examples: Orbitzen 40

03 — Watch out

Red flags to watch for

When you're reading about peptides online, these patterns should trigger your skepticism reflex.

  • "Clinically proven" with no citations — proven by whom? In what study? With how many participants? If the claim doesn't link to a specific trial, it's marketing copy, not science.
  • Forum testimonials as primary evidence — survivorship bias, placebo effect, and zero controls. The people who didn't get results aren't posting about it.
  • Vendor-funded "research" — if the company selling the product also funded or conducted the study, that's a conflict of interest. It doesn't automatically invalidate the findings, but it should make you look harder.
  • Animal studies presented as human proof — mice aren't people. A mouse study is a starting point, not a finish line. Roughly 90% of drugs that work in animal models fail in human trials.
  • Dose extrapolation from animals to humans — "the mouse dose converts to X mg in humans" is speculation dressed up as math. Allometric scaling is a rough estimate, not a prescription.
  • "No side effects" claims — everything that does something also does side effects. If someone claims a bioactive compound has zero downsides, they either haven't looked or aren't telling you.
  • Mixing approved drug data with grey-market products — the FDA approved Ozempic (manufactured by Novo Nordisk under strict quality controls), not a random vial labeled "1G-SGT" from an unregulated compounder. The active ingredient might be the same. The purity, sterility, and dosing accuracy might not be.
04 — Do it yourself

How to verify a claim yourself

You don't need a science degree. You need 10 minutes and a healthy distrust of marketing.

  1. Check the evidence tier badge in BadgerSkope. This is your first filter. If it says "Animal Only," you already know the claim hasn't been proven in humans.
  2. Click the linked sources. Do they actually say what's being claimed? Read the abstract, at minimum. You'd be surprised how often a citation doesn't support the claim it's attached to.
  3. Look at the study design. How many people were in the trial? Was there a control group? How long did it run? A 12-person, 4-week study tells you something very different than a 3,000-person, 2-year trial.
  4. Check who funded the study. Industry-funded research isn't automatically wrong, but it's worth noting. Independent replication carries more weight.
  5. Search PubMed yourself. Go to pubmed.ncbi.nlm.nih.gov and search the compound name. See what comes up. Read a few abstracts. It takes five minutes.
  6. Remember: one study does not equal proof. Science works by replication. A single positive result is a signal. Multiple independent studies finding the same thing is evidence. Look for consistency across research groups.
05 — Fine print that matters

Understanding the disclaimer

Every page on BadgerSkope says "not medical advice." This isn't a legal dodge and it isn't a formality. It means something specific.

Translating research into plain language is not the same as prescribing a treatment. A research summary can tell you what the evidence says — it cannot tell you what you should do with your body, your health conditions, your medications, or your risk tolerance. That's what a licensed medical professional is for.

BadgerSkope exists to help you ask better questions, not to replace the person who should be answering them. When you walk into a doctor's office knowing the difference between Phase 3 trial data and a mouse study, you have a better conversation. That's the goal.

We don't sell anything. We don't recommend anything. We show you what the evidence says, tell you how strong it is, and trust you to make informed decisions with the people qualified to help you make them.